Screening and Treatment of SAHS in Patients With Acute Ischemic Stroke

NCT ID: NCT02029183

Last Updated: 2014-01-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-12-31

Study Completion Date

2017-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ischemic stroke is a kind of common disease with great harm. In acute stage of stroke there is sharply increasing morbidity of sleep apnea hypopnea syndrome. Our suppose that treatment with noninvasive ventilation for patients with acute ischemic stroke should improve the functional prognosis(measuring with 90d modified Rankin score).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In acute state of ischemic stroke,if patients with sleep apnea hypopnea syndrome may need additional respiratory management such bi-level positive airway pressure.We supposed the patients with stroke can take benefit of functional recovery form bi-level positive airway pressure. We choose the patients who suffered ischemic stroke in 48 hours ,then evaluate the respiratory status. Stroke patients who were diagnosed as sleep apnea hypopnea syndrome will accept additional treatment with bi-level positive airway pressure for 7 night(per night 6 hours).Then the modified Rankin scale score and NIHSS will be recorded at 30 days and 90 days after stroke.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Stroke Sleep Apnea Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

bi-level positive airway pressure

bi-level positive airway pressure for 6 hour per night,total 7 days

Group Type EXPERIMENTAL

Bi level positive pressure ventilation

Intervention Type DEVICE

Bi level positive pressure ventilation should be given for subject for 6 hours per night ,total 7 times.

bi-level positive airway pressure

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bi level positive pressure ventilation

Bi level positive pressure ventilation should be given for subject for 6 hours per night ,total 7 times.

Intervention Type DEVICE

bi-level positive airway pressure

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ischeic stroke onset within 48 hours , NIHSS:4-15

Exclusion Criteria

* mRs\>2 before onset of enrollment severe hepatic renal insufficiency cancer in reached an advanced stage
Minimum Eligible Age

35 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dongsheng Fan

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dongsheng Fan, P

Role: STUDY_CHAIR

Peking University Third Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking university third hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Liping Wang, Doctor

Role: primary

0086-010-13810002694

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2694-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stroke and CPAP Outcome Study 3
NCT06029959 COMPLETED NA
Sleep for Stroke Management and Recovery Trial
NCT03812653 ACTIVE_NOT_RECRUITING NA
Stroke and CPAP Outcome Study 2
NCT02809430 COMPLETED NA